Every intervention Outliyr has scored for hormone balance, ranked by its BioHarmony score for this use case rather than its overall rating. The number beside each name is how well that one thing works for hormone balance; the tier beside it is what it is worth once safety, cost and effort are counted across everything else.
43 of 92 evaluated interventions score 3.0+ out of 10 for hormone balance · 13 comparisons
TRT (Testosterone Replacement Therapy) earns 9.0/10 for hormonal because Lincoff 2023 reports TRAVERSE cardiovascular outcomes trial in 5,246 hypogonadal men with cardiovascular risk; major cardiovascular events non-inferior, with monitoring-relevant safety signals. Cruickshank…
Read the TRT (Testosterone Replacement Therapy) report →Berberine gets 7.6/10 for hormonal; the evidence supports a narrow read. The best hormonal case is insulin-resistant PCOS, where berberine can improve insulin sensitivity and downstream androgen and ovulation markers. Zhang 2021…
Read the Berberine report →Shilajit hormonal earns 7.5/10 because Pandit 2016 anchors the most relevant signal. Shilajit fits hormonal when purified resin is matched to hormones, sperm parameters, strength fatigue, bone markers, or energy tracking. The…
Read the Shilajit report →For hormonal, Tesamorelin lands at 7.5/10 because Russo et al. 2024 supports the core mechanism. Tesamorelin directly stimulates the GHRH receptor and raises IGF-1 through a feedback-intact pituitary pathway. Falutz 2007 supports…
Read the Tesamorelin report →The hormonal use case scores 7.0/10 because Metformin improves ovulation in insulin-resistant PCOS, showing about a 30% increase in ovulation odds in a meta-analysis of 13 trials Lord 2003. This evidence sits…
Read the Metformin report →Hormonal scoring is 6.8/10 because Hofling 2013 reported thyroid-related improvements in chronic autoimmune thyroiditis, including lower anti-TPO antibodies and reduced levothyroxine need. That is a specific thyroid signal, not proof of broad…
Read the Red Light Therapy report →For hormonal, Infrared Sauna lands at 6.5/10 because Oosterveld 2009 supports the strongest part of the claim. The existing rationale points to this narrower claim: Sauna can acutely shift prolactin, growth hormone,…
Read the Infrared Sauna report →The hormonal case for Tongkat Ali is 6.5/10 because Talbott 2013 gives the most relevant evidence anchor. The existing rationale points to this narrower claim: the cited study meta-analysis found a significant…
Read the Tongkat Ali report →Population fit explains the 6.5/10 hormonal score for Ashwagandha because the evidence points to a plausible use case without proving a universal response. Lopresti et al. 2019 is the best anchor here…
Read the Ashwagandha report →Vitamin D3 + K2 hormonal earns 6.4/10 because Jolliffe 2021 anchors the most relevant signal. Vitamin D3 + K2 fits hormonal when deficiency, bone risk, immune seasonality, or fat-soluble nutrient gaps are…
Read the Vitamin D3 + K2 report →Tirzepatide is an endocrine drug with strong glucose, insulin, appetite, and body weight effects. It may indirectly improve obesity linked reproductive hormone patterns. PCOS like insulin resistance is the clearest beneficiary group.…
Read the Tirzepatide report →Hormonal scoring is 6.0/10 because Semaglutide improves insulin and weight biology, two upstream drivers of testosterone, estrogen balance, and ovulation in metabolic dysfunction. Wilding 2021 anchors the weight-loss effect, but Semaglutide is…
Read the Semaglutide report →Blood-Flow Restriction Training has a 5.5/10 hormonal case because Wortman et al. 2021 supports a plausible benefit. BFR can create acute growth-hormone and IGF-1 signaling changes, but endocrine spikes are not the…
Read the Blood-Flow Restriction Training report →Essential Amino Acids is a 5.5/10 hormonal fit because Hagiyama 2024 reports 12 RCTs; 622 patients; low-certainty improvement in patient-reported outcomes and very-low-certainty strength signal after lower-limb surgeries. Wittholz 2024 points in…
Read the Essential Amino Acids report →Evidence for Molecular Hydrogen in hormonal lands at 5.5/10 because Dhillon 2024 reports 25-article systematic review; mixed preliminary clinical evidence, heterogeneity, and need for stronger trials. Zhou 2024 points in the same…
Read the Molecular Hydrogen report →The practical hormonal read is 5.5/10 for Phosphatidylserine, with Cenacchi et al. 1993 setting the ceiling. Cortisol blunting is the most reproducible physiology signal outside cognition. Monteleone 1992, Hellhammer 2004, and Starks…
Read the Phosphatidylserine report →A 5.5/10 for hormonal fits Retatrutide because Sanyal 2024 supports direction more than certainty. The existing rationale points to this narrower claim: Insulin normalization and large fat loss can improve obesity-linked sex-hormone…
Read the Retatrutide report →CJC-1295 earns 5.5/10 for hormonal because Teichman 2006 reports CJC-1295 human pharmacology; supports sustained GH/IGF-1 increase and short-duration tolerability, not body-composition or longevity outcomes. Ionescu 2006 points in the same direction, but…
Read the CJC-1295 report →The practical hormonal read on Zone 2 Cardio is 5.0/10 because Vabishchevich 2026 anchors the strongest signal. The existing rationale points to this narrower claim: Zone 2 can support hormone balance indirectly…
Read the Zone 2 Cardio report →The hormonal case for Saffron lands at 5.0/10 because the evidence points to a plausible use case without proving a universal response. Zhang et al. 2025 is the best anchor here because…
Read the Saffron report →Glycine hormonal earns 5.0/10 because Soh 2024 anchors the most relevant signal. Glycine fits hormonal because glycine participates in sleep signaling, glutathione, collagen, methylation, and nervous-system balance, depending on the endpoint. The…
Read the Glycine report →TB-500 (Thymosin Beta-4 Fragment) belongs in the 5.0/10 range for hormonal because the signal is conditional. TB-500 is not an endocrine lever. No hormonal disruption signal is obvious in the clinical-trial literature,…
Read the TB-500 (Thymosin Beta-4 Fragment) report →Wang et al. 2024 reported a modest acute increase in growth hormone of roughly ten percent after a single Whole-Body Vibration session. The hormonal use case for Whole-Body Vibration therefore rests on…
Read the Whole-Body Vibration report →For hormonal, the 5.0/10 score reflects how Senolytics performs in Silva et al. 2024. Any endocrine benefit is indirect through metabolic and inflammatory-cell senescence; no verified human hormonal F+Q endpoint exists. The…
Read the Senolytics report →Ca-AKG (Calcium Alpha-Ketoglutarate)'s 5.0/10 hormonal score starts with Shahmirzadi 2020, then gets narrowed by the evidence gap. The existing rationale points to this narrower claim: No direct hormonal data. Current evidence does…
Read the Ca-AKG (Calcium Alpha-Ketoglutarate) report →Hormonal and endocrine support is the core mechanism: kisspeptin-10 sits at the top of the reproductive axis and drives LH, FSH, and downstream sex hormones. Continuous infusion raised testosterone in healthy and…
Read the Kisspeptin-10 report →Hormonal regulation is gonadorelin's core competency and its highest score, because it is literally the master hormone of the reproductive axis. As synthetic GnRH it binds the pituitary GnRH receptor and drives…
Read the Gonadorelin (GnRH) report →Modulates HPA axis; may reduce cortisol in chronic-stress populations.
Read the HRV Biofeedback report →HIIT can acutely raise growth hormone and catecholamines, with transient testosterone changes in some users. Chronic hormonal benefit depends more on recovery and avoiding overtraining.
Read the Norwegian 4×4 report →Limited exercise-stress and fertility-adjacent hormonal data. Not a testosterone or endocrine intervention.
Read the Astaxanthin report →Hormonal effect scores 4.0/10. Acute sauna transiently raises growth hormone and cortisol, but these are short-lived stress responses, not a durable endocrine intervention. No outcome evidence supports sauna as a hormonal therapy,…
Read the Traditional Sauna (Finnish Dry-Heat) report →INSUFFICIENT_EVIDENCE for broad hormonal optimization; endocrine benefit was not significant in the human systematic review and reproductive warnings raise downside.
Read the Rapamycin report →Hormonal effects split by phenotype. Iacovides 2022 reported thyroid-function shifts in a pilot crossover trial, and Svart 2024 found lower free testosterone and free estradiol after three weeks in middle-aged adults with…
Read the Ketogenic Diet report →Exogenous ketones have acute endocrine effects, notably ghrelin suppression (Stubbs 2018) and modest shifts in insulin and glucagon, but they are not an endocrine therapy. People with type 1 diabetes must be…
Read the Exogenous Ketones report →Hormonal scores 3.5/10, mostly via soy isoflavones acting as weak phytoestrogens; this is member-specific, not a class-wide endocrine effect.
Read the Polyphenols (Dietary) report →High-intensity contractions can acutely influence anabolic hormones, similar to resistance training. Durable testosterone, growth-hormone, or endocrine changes from WB-EMS have not been proven as a major clinical effect.
Read the Full-Body EMS report →Thymosin alpha-1 is a thymic peptide hormone but not a direct endocrine modulator. Effects on classic hormones such as thyroid, testosterone, cortisol, or insulin are not established in controlled human trials.
Read the Thymosin Alpha-1 report →Melatonin secretion restoration in elderly adults is the most relevant hormonal signal, but the audit found the human citation trail blends Epitalon with epithalamin. Korkushko 2004 confirms pineal extract modulation of nocturnal…
Read the Epitalon report →Hormonal support is pine pollen's headline use case, and it scores only 3.5 out of 10 because the human evidence is absent. The marketed claim traces to Saden-Krehula 1971, which detected trace…
Read the Pine Pollen report →Hormonal effects are bidirectional and not a positive indication. Resveratrol is a phytoestrogen with estrogen-receptor activity, and Andreani 2017 found tumor-promoting effects in a HER2-positive and ERalpha-positive breast-cancer mouse model through proteasome-inhibition…
Read the Resveratrol report →Limited evidence; some interaction with growth hormone receptor expression in tendon fibroblasts. Chang 2014 supports local tendon-cell signaling, not systemic hormone optimization.
Read the BPC-157 report →Aromatase inhibition is supported in vitro by Sanderson 2004. Whether oral 50-100 mg apigenin reaches sufficient tissue concentrations to alter estrogen-to-testosterone ratio in vivo is unestablished. No human sex-hormone RCT exists.
Read the Apigenin report →Sramek 2000 European Journal of Applied Physiology measured noradrenaline up 530 percent and dopamine up 250 percent during 1 hour of head-out 14 degC immersion in n=10 young men. The acute hormonal…
Read the Cold Plunge report →Nothing matches those filters.
Head-to-head reports and category rankings that name a winner on this use case.
Tesamorelin, at 6.2, and only if you have a clinical reason. Every one of the nine scores 6.2 or lower, so the category tops out at worth trying…
Shilajit at 7.4, phosphatidylserine at 7.3, tongkat ali at 7.0. TRT ranks seventh at 5.7 and wins nine of the eleven use cases outright. That inversion is the…
No. Berberine scores 6.8 and semaglutide 6.0, and that gap misleads almost everyone who reads it. Berberine scores higher because it is cheap, oral and easy to stop,…
Tesamorelin, unless price is the only thing deciding. It is FDA-approved for visceral fat with Phase 3 trials behind it, while CJC-1295 is a gray-market research peptide whose…
No, and the reason is mechanical. A drink raises blood ketones in an hour. It does not lower insulin, deplete glycogen or shift fuel use. The diet scores…
The scores tie at 6.3 and 6.4 and every shared subrating sits within half a point, so the numbers decide nothing. Access and evidence decide it. Gonadorelin is…
Kisspeptin-10 scores 6.4 and TRT 5.7, and TRT still wins 13 of the 15 use cases both reports score. The higher number reflects dependency and reversibility, not effect.…
Shilajit scores 7.4 and ashwagandha 6.8, but that gap is the least useful number here. These two do different jobs. Shilajit is the mineral and androgen play: male…
Thymulin scores 6.6, thymalin 5.9, and they are not interchangeable. Thymulin is a defined zinc-dependent peptide with receptor-level science, stronger inflammation data and a much cheaper course. Thymalin…
Ashwagandha scores 6.8 and tongkat ali 7.0, so the overall numbers do not decide it. Pick ashwagandha when stress, anxiety, or sleep is the complaint: its subratings there…
GHRP-2 scores 5.5 and GHRP-6 scores 5.1. Both are ghrelin-receptor peptides doing the same job, and appetite is the only difference that changes a decision. Pick GHRP-2 for…
Metformin scores 6.9 and berberine 6.8, so the gap is meaningless. Metformin owns blood sugar with decades of outcome trials behind it. Berberine owns fatty liver, needs no…
TRT (Testosterone Replacement Therapy), at 9.0 out of 10 for hormone balance. TRT (Testosterone Replacement Therapy) earns 9.0/10 for hormonal because Lincoff 2023 reports TRAVERSE cardiovascular outcomes trial in 5,246 hypogonadal men with cardiovascular risk; major cardiovascular events non-inferior, with monitoring-relevant safety signals.
Of the top-scoring options, Glycine is the least expensive at about $2 a month, scoring 5.0 out of 10 for hormone balance.
43 of the 92 interventions evaluated for hormone balance score 3.0 out of 10 or better, which is the cut-off for appearing on this page.
